Prospective, natural history study of sars COV-2 infection in wake forest health care workers using innovative sampling kits
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30120C08405
- Awardee
-
Vysnova Partners, LLC UEI WG9BBL96G436
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $27,273,623
Award facts
- Opportunity
-
- Centers for Disease Control COVID-19 Broad Agency Announcement Solicitation · 75D30120Q72026 · Posted Mar 11, 2020
- Centers for Disease Control COVID-19 Broad Agency Announcement Award Notice · Posted Jul 9, 2020
- Contract value 50% obligated
-
- $27,273,623.00 Current, with exercised options
- $54,179,237.36 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Hyattsville, MD, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$46 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $27,273,669 |
About this award
This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023.
The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from offerors for applied research addressing the COVID-19 public health emergency across several topic areas, including surveillance and natural history of SARS-CoV-2 infections. The contract was not set aside for any particular business type.
Vysnova Partners, LLC is a firm that provides professional, scientific, and technical services to support medical research, clinical trials, disease surveillance, and global health initiatives for federal agencies. The company has significant experience supporting Department of Defense, Department of Health and Human Services, and other civilian agency programs, both domestically and internationally.
Quick answers
Who was awarded contract 75D30120C08405?
75D30120C08405 was awarded to Vysnova Partners, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 1, 2020.
How much is contract 75D30120C08405 worth?
The government has obligated $27,273,623 on 75D30120C08405. Its potential value, with all options, is $54,179,237.
Was contract 75D30120C08405 competed?
The extent of competition for 75D30120C08405 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award